BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33657571)

  • 1. Decreasing Attacks and Improving Quality of Life through a Systematic Management Program for Patients with Hereditary Angioedema.
    Nunes FL; Ferriani MPL; Moreno AS; Langer SS; Maia LSM; Ferraro MF; Sarti W; Bessa Junior J; Cunha D; Suffritti C; Dias MM; Januário YC; daSilva LLP; Aragon DC; Caballero T; Arruda LK
    Int Arch Allergy Immunol; 2021; 182(8):697-708. PubMed ID: 33657571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study.
    Lumry WR; Zuraw B; Cicardi M; Craig T; Anderson J; Banerji A; Bernstein JA; Caballero T; Farkas H; Gower RG; Keith PK; Levy DS; Li HH; Magerl M; Manning M; Riedl MA; Lawo JP; Prusty S; Machnig T; Longhurst H;
    Orphanet J Rare Dis; 2021 Feb; 16(1):86. PubMed ID: 33588897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema.
    Lumry WR; Craig T; Zuraw B; Longhurst H; Baker J; Li HH; Bernstein JA; Anderson J; Riedl MA; Manning ME; Keith PK; Levy DS; Caballero T; Banerji A; Gower RG; Farkas H; Lawo JP; Pragst I; Machnig T; Watson DJ
    J Allergy Clin Immunol Pract; 2018; 6(5):1733-1741.e3. PubMed ID: 29391286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergency Department Management of Hereditary Angioedema Attacks: Patient Perspectives.
    Otani IM; Christiansen SC; Busse P; Camargo CA; Zuraw BL; Riedl MA; Banerji A
    J Allergy Clin Immunol Pract; 2017; 5(1):128-134.e4. PubMed ID: 27665386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of recognizing and managing a rare form of angioedema: hereditary angioedema due to C1-inhibitor deficiency.
    Jacobs J; Neeno T
    Postgrad Med; 2021 Aug; 133(6):639-650. PubMed ID: 33993830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between anxiety and quality of life in children with hereditary angioedema.
    Kessel A; Farkas H; Kivity S; Veszeli N; Kőhalmi KV; Engel-Yeger B
    Pediatr Allergy Immunol; 2017 Nov; 28(7):692-698. PubMed ID: 28692169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life among children with hereditary angioedema.
    Engel-Yeger B; Farkas H; Kivity S; Veszeli N; Kőhalmi KV; Kessel A
    Pediatr Allergy Immunol; 2017 Jun; 28(4):370-376. PubMed ID: 28258590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic Treatment in Hereditary Angioedema Is Associated with Reduced Anxiety in Patients in Leipzig, Germany.
    Zarnowski J; Rabe M; Kage P; Simon JC; Treudler R
    Int Arch Allergy Immunol; 2021; 182(9):819-826. PubMed ID: 33887730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of hereditary angioedema in Japan: Focus on icatibant for the treatment of acute attacks.
    Hide M; Horiuchi T; Ohsawa I; Andresen I; Fukunaga A
    Allergol Int; 2021 Jan; 70(1):45-54. PubMed ID: 32919903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.
    Longhurst HJ; Zanichelli A; Caballero T; Bouillet L; Aberer W; Maurer M; Fain O; Fabien V; Andresen I;
    Clin Exp Immunol; 2017 Apr; 188(1):148-153. PubMed ID: 27936514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary angioedema: Epidemiology and burden of disease.
    Lumry WR; Settipane RA
    Allergy Asthma Proc; 2020 Nov; 41(Suppl 1):S08-S13. PubMed ID: 33109318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emotional processes and stress in children affected by hereditary angioedema with C1-inhibitor deficiency: a multicenter, prospective study.
    Savarese L; Bova M; De Falco R; Guarino MD; De Luca Picione R; Petraroli A; Senter R; Traverso C; Zabotto M; Zanichelli A; Zito E; Alessio M; Cancian M; Cicardi M; Franzese A; Perricone R; Marone G; Valerio P; Freda MF
    Orphanet J Rare Dis; 2018 Jul; 13(1):115. PubMed ID: 30005674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-reported burden of hereditary angioedema: findings from a patient survey in the United States.
    Banerji A; Davis KH; Brown TM; Hollis K; Hunter SM; Long J; Jain G; Devercelli G
    Ann Allergy Asthma Immunol; 2020 Jun; 124(6):600-607. PubMed ID: 32169514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary Angioedema: An Updated Experience with Patients with Angioedema in Puerto Rico.
    Rosado-Quiñones AM; Zaragoza-Urdaz R
    P R Health Sci J; 2019 Dec; 38(4):248-254. PubMed ID: 31935311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of COVID-19 on hereditary angioedema activity and quality of life.
    Can Bostan O; Tuncay G; Damadoglu E; Karakaya G; Kalyoncu AF
    Allergy Asthma Proc; 2021 Sep; 42(5):403-408. PubMed ID: 34474710
    [No Abstract]   [Full Text] [Related]  

  • 16. The humanistic burden of hereditary angioedema: results from the Burden of Illness Study in Europe.
    Caballero T; Aygören-Pürsün E; Bygum A; Beusterien K; Hautamaki E; Sisic Z; Wait S; Boysen HB
    Allergy Asthma Proc; 2014; 35(1):47-53. PubMed ID: 24268449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dedicated call center (SOS-HAE) for hereditary angioedema attacks: study protocol for a randomised controlled trial.
    Javaud N; Fain O; Durand-Zaleski I; Launay D; Bouillet L; Gompel A; Sobel A; Woimant M; Rabetrano H; Petrovic T; Lapostolle F; Boccon-Gibod I; Reuter PG; Bertrand P; Coppere B; Floccard B; Kanny G; Martin L; Vicaut E; Adnet F
    Trials; 2016 Apr; 17(1):225. PubMed ID: 27140403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current state of hereditary angioedema management: a patient survey.
    Banerji A; Busse P; Christiansen SC; Li H; Lumry W; Davis-Lorton M; Bernstein JA; Frank M; Castaldo A; Long JF; Zuraw BL; Riedl M
    Allergy Asthma Proc; 2015; 36(3):213-7. PubMed ID: 25976438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, effectiveness, and impact on quality of life of self-administration with plasma-derived nanofiltered C1 inhibitor (Berinert®) in patients with hereditary angioedema: the SABHA study.
    Zanichelli A; Azin GM; Cristina F; Vacchini R; Caballero T
    Orphanet J Rare Dis; 2018 Apr; 13(1):51. PubMed ID: 29631595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and burden of illness in patients with hereditary angioedema: findings from a multinational patient survey.
    Mendivil J; Murphy R; de la Cruz M; Janssen E; Boysen HB; Jain G; Aygören-Pürsün E; Hirji I; Devercelli G
    Orphanet J Rare Dis; 2021 Feb; 16(1):94. PubMed ID: 33602292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.